© 2022 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
January 17, 2022
Closing out his discussion on CGP, David Gandara, MD, looks toward future opportunities for CGP in screening patients before or after surgery.
January 12, 2022
Considering the value of comprehensive genomic profiling, David Gandara, MD, highlights the importance of supporting access to testing.
A brief discussion on the value of commercially available comprehensive genomic profiling over homegrown testing.
January 05, 2022
David Gandara, MD, explains how the scope of comprehensive genomic profiling has shifted from a select few patients to the majority.
A review of how comprehensive genomic profiling can better inform treatment planning and alleviate health care economic burden.
December 23, 2021
Expert perspective on clinical and personal improvements in cancer care made available by appropriate use of comprehensive genomic profiling.